Pathogenic bacteria are usually destroyed by antibodies, but a lung-damaging bacterium turns the body's antibody response in its favour, suggests a study published in The Journal of Experimental Medicine.
Pathogenic bacteria are normally destroyed by antibodies, immune proteins that coat the outer surface of the bug, laying a foundation for the deposition of pore-forming "complement" proteins that poke lethal holes in the bacterial membrane. But despite having plenty of antibodies and complement proteins in their bloodstream, some people can't fight off infections with the respiratory bacterium Pseudomonas aeruginosa. And chronic infection can lead to a condition called bronchiectasis, characterized by persistent cough, shortness of breath, and chest pain.
Targeted Antibodies may Block Spread and Development of Parkinson's Disease
Immunotherapy with targeted antibodies could block the development and spread of PD, a new cell culture and mouse model developed by researchers has revealed
A group of researchers at the University of Birmingham, England, now find that the antibody response to Pseudomonas can get in its own way. In a subset of infected bronchiectasis patients with particularly poor lung function, they noticed an abundance of one specific type of antibody, called IgG2, which stripped the blood of its normal bug-killing capacity. The IgG2 proteins bound to extra-long sugars on the bacterial surface, a feature unique to the bugs infecting these patients. When these sugar-specific antibodies were removed, the blood's antibacterial prowess was restored.
Source: Eurekalert
Diet for Obstructive Lung Disease
The right balance of energy boosting foods and protein foods along with adequate vitamin and mineral intake is the right diet for COPD.
 Brodalumab - A New Promising Treatment for PsoriasisA new drug, brodalumab appears to be effective in moderate-to-severe psoriasis. | Advertisement
|
Recommended Readings
Latest Research News
